4//SEC Filing
De Rosch Mark 4
Accession 0000899243-21-042089
CIK 0001501796other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 7:28 PM ET
Size
7.4 KB
Accession
0000899243-21-042089
Insider Transaction Report
Form 4
De Rosch Mark
Chief Operating Officer
Transactions
- Award
Common Stock
2021-10-28+17,500→ 17,500 total - Award
Stock Option (Right to Buy)
2021-10-28+75,000→ 75,000 totalExercise: $14.00Exp: 2031-10-27→ Common stock (75,000 underlying)
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2021 Stock Option and Incentive Plan. Each restricted stock unit represents the right to receive one share of the Company's common stock. These restricted stock units vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant.
- [F2]The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2021 with the remainder vesting thereafter pro-rata in 36 monthly installments.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001890320
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 7:28 PM ET
- Size
- 7.4 KB